<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,92.176,94.193,98.318,102.054,106.179,107.658,113.022,115.039,116.558,124.03,128.154,131.031,134.296,137.561,139.579,145.809,149.545,153.67,157.795,159.301,162.178,164.584,166.601,168.088,173.453,176.718,178.235,182.748,184.765,186.286,189.551,191.957,193.485,197.221,199.239,201.256,202.783,208.147,210.165,212.182,216.307,218.324,221.589,225.325,227.34199999999998,228.859,232.124,235.86,239.596,241.613,245.738,249.474,251.88,253.897,258.11,262.235,263.723,267.848,270.254,271.774,275.899,279.635,282.9,287.025,291.149,294.885,299.009,301.027,305.152,306.695,309.96,313.696" y="37.76400000000001" svg_rhmargin="316.961" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Singh R, Wurzelmann JI, Ye L, et al. Clinical evaluation of pazopanib eye</text>
  <text x="88.441,92.565,95.442,99.566,103.691,106.568,109.416,111.433,115.558,118.373,122.497,125.763,129.498,131.516,133.922,138.046,141.78199999999998,144.677,147.553,151.678,155.802,157.82,161.085,164.35,166.756,169.633,172.511,176.246,180.371,184.496,187.307,189.324,193.449,196.264,199.141,203.265,207.39,209.407,212.672,215.937,218.429,221.306,224.099,229.853,231.87,234.276,238.401,241.277,245.401,248.666,252.791,256.526,260.262,263.139,266.404,270.529,272.624,276.36,279.237,282.035,285.771,289.507,292.772,295.178,298.055,301.32,303.337,307.073,309.479,312.744" y="46.721000000000004" svg_rhmargin="316.868" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">drops in healthy subjects and in subjects with neovascular age-related</text>
  <text x="88.441,94.583,98.319,101.584,105.708,107.726,111.461,114.338,116.842,120.966,124.232,127.967,131.298,135.422,138.687,141.564,145.3,147.706,149.723,153.848,157.972,159.989,162.533,167.897,171.163,173.569,175.586,179.71,183.446,185.945,190.069,194.194,198.318,202.443,204.46,208.584,212.709,214.799,218.923,223.048,227.172" y="55.678" svg_rhmargin="231.296" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">macular degeneration. Retina 2014;34:1787</text>
  <text x="231.306" y="55.678" svg_rhmargin="235.042" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="235.048,239.173,243.298" y="55.678" svg_rhmargin="245.315" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">95.</text>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,93.805,97.929,101.194,104.071,108.196,111.461,115.586,117.635,122.148,124.16499999999999,126.195,129.931,134.055,136.073,138.479,141.744,145.009,147.886,149.947,157.419,161.155,163.172,165.196,170.099,173.835,176.24,179.976,182.853,184.925,191.067,193.084,195.072,198.338,200.744,202.783,206.518,208.536,210.553,212.59,216.326,220.062,222.468,225.733,228.139,231.875,233.962,238.086,240.963" y="64.63599999999997" svg_rhmargin="245.087" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Yoeruek E, Spitzer MS, Tatar O, et al. Safety pro</text>
  <text x="245.083" y="64.63599999999997" svg_rhmargin="249.207" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="249.221,251.239,254.504,256.535,260.659,263.065,265.095,269.22,272.485,276.221,279.956,283.222,285.239,288.504,292.629,298.77,302.506,306.631,308.689,312.814" y="64.63599999999997" svg_rhmargin="316.938" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le of bevacizumab on</text>
  <text x="88.441,91.706,95.83,97.848,100.254,104.378,107.255,110.52,114.645,117.182,121.306,125.431,131.573,135.308,139.433,141.955,145.22,149.344,152.221,156.345,159.611,163.346,165.363,167.861,171.126,174.391,176.409,178.426,181.303,183.32,185.888,191.253,195.377,198.254,202.378,205.644,209.38,211.908,216.032,220.157,224.281,228.406,230.423,234.547,238.672,240.689,244.814,248.938" y="73.59299999999996" svg_rhmargin="253.062" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cultured human corneal cells. Cornea 2007;26:977</text>
  <text x="253.133" y="73.59299999999996" svg_rhmargin="256.869" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="256.875,261.0,265.125" y="73.59299999999996" svg_rhmargin="267.142" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">82.</text>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,94.582,98.707,102.783,105.66,111.024,113.041,117.182,122.547,124.565,130.707,134.813,142.285,147.65,149.667,153.747,157.483,161.608,163.625,167.75,171.888,179.36,183.096,185.113,189.179,192.444,194.85,198.986,202.722,204.739,206.756,210.834,215.736,219.86,223.125,227.218,230.953,235.078,237.484,239.501,241.907,243.924" y="82.54999999999995" svg_rhmargin="248.048" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[28] Oh JY, Kim MK, Shin MS, et al. The anti-in</text>
  <text x="248.087" y="82.54999999999995" svg_rhmargin="252.211" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="252.226,255.962,262.103,268.245,271.981,274.387,278.511,281.476,285.212,289.3,292.565,294.971,297.377,300.642,303.907,306.313,310.445,314.57" y="82.54999999999995" svg_rhmargin="316.976" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory effect of</text>
  <text x="88.441,91.317,95.442,99.566,102.832,106.956,111.08,113.098,117.222,121.347,124.612,127.018,129.035,132.771,136.507,138.524,141.671,145.795,149.06,152.796,156.532,159.797,161.815,165.08,169.204,175.346,179.082,183.207,186.341,190.466,194.591,197.68,200.945,205.07,208.335,214.477,216.494,219.759,223.495,225.513,227.53,231.266,234.414,238.539,242.663,245.54,249.664,252.93,257.055,260.151,263.028,266.764,269.17,272.283,275.548,279.673,282.549,286.674,289.939,293.675,296.551,298.568,301.704,307.069,311.193,314.07" y="91.56399999999996" svg_rhmargin="316.947" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">subconjunctival bevacizumab on chemically burned rat corneas. Curr</text>
  <text x="88.441,92.954,96.69,99.955,102.443,107.808,111.074,113.951,116.446,120.57,124.695,128.819,132.944,134.961,139.085,143.21,145.3,149.425" y="100.52099999999996" svg_rhmargin="153.549" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Eye Res 2009;34:85</text>
  <text x="153.524" y="100.52099999999996" svg_rhmargin="157.26" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="157.266,161.391,165.516" y="100.52099999999996" svg_rhmargin="167.533" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">91.</text>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,93.805,95.822,101.964,104.653,109.166,114.531,116.548,119.279,123.792,127.057,130.322,133.055,140.528,144.263,146.28,148.986,154.35,156.368,162.51,165.255,172.728,176.464,178.481,181.186,186.088,190.212,193.47699999999998,196.152,198.169,202.294,206.418,208.51,212.635,214.652,217.058,221.183,224.059,227.795,230.506,233.771,236.177,238.583,241.848,245.113,247.519,250.39600000000002,253.125,257.249,259.65500000000003,262.365,266.489,269.754,273.49,277.226,280.491,282.509,285.774,289.972,296.113,299.849,303.974,306.695,309.96,313.696" y="109.47799999999995" svg_rhmargin="316.961" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[29] Kim EC, Lee WS, Kim MS. The inhibitory effects of bevacizumab eye</text>
  <text x="88.441,92.565,95.442,99.566,103.691,106.568,109.812,113.937,118.062,121.377,127.519,133.272,137.397,140.652,143.917,148.041,152.166,155.042,158.307,161.184,164.061,166.161,170.285,174.41,177.669,181.405,185.529,189.654,192.919,196.184,200.309,203.185,207.31,210.575,214.311,216.328,219.62,225.373,229.497,233.622,237.746,241.871,245.187,249.312,252.577,256.313,258.33,260.348,264.472,268.20799999999997,271.491,273.508,277.633,280.902,283.778,287.514,289.92,292.797,294.814,298.079,300.485,304.609,308.345,311.61,314.487" y="118.43600000000004" svg_rhmargin="316.893" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">drops on NGF expression and corneal wound healing in rats. Invest</text>
  <text x="88.441,94.583,98.707,102.832,105.237,109.362,113.098,115.115,121.257,125.381,127.398,129.936,135.301,137.318,140.19500000000002,142.691,146.427,149.692,151.709,154.256,158.381,162.505,166.63,170.754,172.771,176.896,181.02,183.038,187.162,191.286,195.411" y="127.39300000000003" svg_rhmargin="199.535" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Ophthalmol Vis Sci 2010;51:4569</text>
  <text x="199.615" y="127.39300000000003" svg_rhmargin="203.351" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="203.357,207.482,211.607" y="127.39300000000003" svg_rhmargin="213.624" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="72.057,74.463,78.588,82.712,85.11800000000001,88.441,92.954,97.171,100.516,104.641,109.416,113.541,115.55799999999999,120.357,126.499,130.731,134.927,138.272,141.22,145.416,149.152,153.862,156.811,158.828,163.614,168.979,173.195,179.431,185.667,188.932,191.053,193.459,198.196,203.638,205.655,210.441,213.706,216.112,220.929,224.728,226.745,228.762,233.572,237.37,241.169,243.575,246.951,249.446,253.182,257.893,262.088,265.037" y="136.35000000000002" svg_rhmargin="269.161" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[30] Bock F, Onderka J, Rummelt C, et al. Safety pro</text>
  <text x="269.234" y="136.35000000000002" svg_rhmargin="273.358" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="273.43,275.524,278.789,283.518,287.719,290.125,294.862,297.345,301.546,305.748,307.765,311.107,314.92" y="136.35000000000002" svg_rhmargin="316.937" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le of topical</text>
  <text x="88.442,93.887,98.401,104.234,108.359,114.041,118.246,121.511,125.715,128.201,131.158,134.974,137.071,139.088,142.434,146.249,148.735,150.833,154.957,159.082,164.779,168.595,171.001,176.645,179.131,183.335,186.6,192.235,195.58,199.785,202.741,206.946,210.291,214.107,216.124,221.76,224.246,228.371,232.24,235.505,238.462,240.868,246.512,252.734,256.938,261.143,263.628,267.753,271.565,273.662,279.884,284.088,286.105,291.742,297.186,299.284,302.161,307.787,311.586,314.931" y="145.36400000000003" svg_rhmargin="316.948" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci</text>
  <text x="88.442,92.643,96.768,100.969,105.169,107.263,111.464,115.664,117.758,121.959,126.083,130.284" y="154.32100000000003" svg_rhmargin="134.408" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2009;50:2095</text>
  <text x="134.477" y="154.32100000000003" svg_rhmargin="138.213" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="138.275,142.471,146.666,150.862" y="154.32100000000003" svg_rhmargin="152.879" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">102.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.442,93.807,97.932,101.197,105.322,109.871,117.343,119.749,124.262,126.279,130.79,135.303,137.321,141.446,145.983,151.348,153.754,158.656,160.673,165.201,169.714,171.731,175.856,180.394,186.537,188.943,193.844,195.861,200.406,203.671,206.077,210.61,214.346,216.363,218.38,222.912,226.647,230.772,234.896,238.161,242.355,246.481,248.498,252.622,256.747,260.012,262.418,264.435,268.171,271.907,273.924,278.467,280.484,284.608,286.626,289.891,293.156,295.562,297.579,301.704,305.829,310.382,314.507" y="163.27800000000002" svg_rhmargin="316.913" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[31] Chen W-L, Lin C-T, Lin N-T, et al. Subconjunctival injection of</text>
  <text x="88.443,92.568,95.833,99.569,103.304,106.57,108.587,111.852,115.977,122.118,125.854,129.97899999999998,132.263,134.669,138.405,142.141,145.877,148.753,151.159,153.177,157.301,159.707,161.968,166.092,170.217,172.455,175.72,179.845,182.722,186.911,190.176,193.912,195.929,198.135,202.26,205.525,209.649,213.385,217.182,220.059,223.324,227.448,229.466,233.202,236.078,238.096,241.361,245.097,247.503,249.52,253.645,257.77,260.038,262.056,266.181,268.428,272.553,274.57,276.976,279.382,282.647,285.524,288.789,292.913,295.319,297.623,300.499,304.235,308.36,312.484,314.502" y="172.236" svg_rhmargin="316.908" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">bevacizumab (avastin) on corneal neovascularization in different rabbit</text>
  <text x="88.443,94.585,98.709,102.834,106.099,108.116,110.993,114.52,118.644,121.05000000000001,124.554,127.819,131.943,134.82,138.944,142.209,145.945,147.962,151.48,155.216,159.341,163.077,165.094,169.218,172.954,176.22,180.344,183.679,186.556,188.573,191.45,193.46699999999998,196.945,199.351,203.475,207.211,210.476,213.353,215.75900000000001,219.28,225.422,229.547,233.736,236.142,240.266,244.002,246.02,252.161,256.286,258.303,261.853,267.218,269.235,272.112,275.572,279.308,282.573,284.59,288.101,292.225,296.35,300.474,304.599,306.694,310.82,314.944" y="181.19299999999998" svg_rhmargin="316.961" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">models of corneal angiogenesis. Invest Ophthalmol Vis Sci 2009;50:</text>
  <text x="88.443,92.568,96.693,100.819" y="190.14999999999998" svg_rhmargin="104.943" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">1659</text>
  <text x="104.941" y="190.14999999999998" svg_rhmargin="108.677" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="108.683,112.808,116.933" y="190.14999999999998" svg_rhmargin="118.95" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">65.</text>
  <text x="72.059,74.465,78.59,82.714,85.12,88.443,92.64,95.905,98.422,101.372,105.568,109.377,111.467,115.664,119.789,122.807,128.249,130.266,133.295,137.887,141.695,143.785,147.594,151.402,155.21,159.019,163.144,166.162,171.599,175.407,177.424,180.453,186.292,190.101,193.05,195.45600000000002,198.492,201.441,206.878,208.89499999999998,211.924,215.261,217.667,220.704,224.512,226.602,228.619,231.648,235.446,239.643,243.84,247.178,251.303,255.512,257.602,261.798,265.995,269.333,271.739,273.868,277.677,281.485,283.502,286.531,290.728,294.065,297.874,301.682,305.02,307.11,310.375,314.572" y="199.10699999999997" svg_rhmargin="316.978" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[32] Petsoglou C, Balaggan KS, Dart JK, et al. Subconjunctival bevacizu-</text>
  <text svg_rhmargin="316.964" x="88.443,94.586,98.421,102.546,109.135,111.233,115.431,119.63,123.828,127.093,130.432,133.309,139.9,142.85,146.19,149.999,152.95,156.215,159.186,162.137,164.228,168.426,172.551,179.141,183.339,185.745,192.297,195.636,199.834,202.785,206.983,210.248,214.126,216.143,222.687,226.882,230.221,234.42,238.229,242.039,244.99,248.329,252.454,254.546,258.355,261.306,263.397,266.348,270.158,272.564,274.693,278.892,283.09,285.10699999999997,291.707,295.443,302.025,306.221,308.238,310.359,314.558,316.964" y="37.75999999999999" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">mab induces regression of corneal neovascularisation: a pilot </text>
  <text x="348.436,351.391,355.205,359.408,363.611,367.814,373.956,376.091,379.039,382.383,386.508,389.072,393.275,395.371,399.186,402.529,405.794,410.012,414.215,416.699,420.043,424.167,428.37,430.855,433.81,438.013,440.109,442.126,445.47,449.595,452.159,456.362,460.565,464.768,468.971,471.066,474.332,476.849,483.069,486.883,489.839,493.964,497.307,501.432,503.997,506.481,509.436,511.532,515.346,517.364,519.3810000000001,521.979,526.571,529.448,532.013,534.89,537.512,543.655,547.858,552.061,554.545,558.669,562.484,564.58,570.8,575.003" y="37.75999999999999" svg_rhmargin="577.02" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">randomised placebo-controlled double-masked trial. Br J Ophthalmol</text>
  <text x="348.436,352.633,356.831,361.029,365.226,367.317,371.441,375.65,377.741,381.938" y="46.716999999999985" svg_rhmargin="386.062" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2013;97:28</text>
  <text x="386.136" y="46.716999999999985" svg_rhmargin="389.872" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="389.935,394.13,398.326" y="46.716999999999985" svg_rhmargin="400.343" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,353.8,355.817,361.959,364.761,368.497,375.969,377.986,380.747,386.971,390.707,393.503,398.015,400.892,402.909,405.691,411.056,413.073,419.215,422.018,426.531,431.896,433.913,436.701,439.966,442.372,445.148,448.883,450.901,452.918,455.692,460.593,464.718,467.983,470.715,473.98,476.386,478.792,482.057,485.322,487.728,490.556,494.68,497.086,499.853,502.259,506.383,510.508,512.525,515.79,519.526,521.543,524.343,528.467,531.732,535.468,539.204,542.469,544.487,547.752,551.95,558.091,561.827,565.952,568.73,572.855" y="55.67399999999998" svg_rhmargin="576.979" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[33] Kim SW, Ha BJ, Kim EK, et al. The effect of topical bevacizumab on</text>
  <text x="348.436,351.701,355.825,358.702,362.826,366.091,369.827,371.844,374.399,378.523,381.788,385.913,389.648,393.384,396.261,399.526,403.651,405.668,409.404,412.281,414.298,417.651,421.387,423.793,425.811,429.935,434.059,436.076,438.569,444.711,448.836,452.96,455.366,459.49,463.226,465.326,471.468,475.592,477.609,481.734,485.47,489.206,491.686,495.811,499.935,504.06,508.184,510.201,514.326,518.45,522.575,524.679,527.944,532.068" y="64.63099999999997" svg_rhmargin="536.192" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">corneal neovascularization. Ophthalmology 2008;115:e33</text>
  <text x="536.201" y="64.63099999999997" svg_rhmargin="539.937" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="539.943,544.068,548.193" y="64.63099999999997" svg_rhmargin="550.21" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">38.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,353.8,357.924,361.189,365.314,367.331,371.067,374.228,379.593,381.61,384.772,389.285,393.41,396.675,400.8,403.933,408.057,410.074,413.173,419.397,423.522,426.398,430.523,433.638,437.762,439.779,442.935,446.2,448.606,451.722,455.458,457.475,459.492,462.606,466.342,470.466,474.591,477.467,479.873,482.279,485.452,489.188,493.312,497.437,500.531,502.549,506.673,510.798,514.534,516.939,519.345,522.697,525.573,531.715,534.829,537.705,541.441,543.847,547.112,549.518,553.254,556.427,560.552,563.428" y="73.58900000000006" svg_rhmargin="567.552" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[34] Koenig Y, Bock F, Horn F, et al. Short- and long-term safety pro</text>
  <text x="567.552" y="73.58900000000006" svg_rhmargin="571.676" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="571.691,573.708" y="73.58900000000006" svg_rhmargin="576.973" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le</text>
  <text x="348.436,352.172,356.297,360.422,362.553,365.818" y="82.54600000000005" svg_rhmargin="368.224" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and ef</text>
  <text x="368.278" y="82.54600000000005" svg_rhmargin="372.402" style="fill:#171615;font-family:DPNDHD+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="372.416,375.682,379.417,382.683,386.419,388.516,392.64,395.046,397.189,399.595,403.719,407.844,409.861,413.126,416.862,418.879,421.055,425.179,428.444,432.18,435.916,439.181,441.199,444.464,448.661,454.803,458.539,462.664,464.761,467.167,472.532,476.267,480.003,482.958,485.364,487.381,491.505,493.911,496.053,499.318,503.054,506.31899999999996,508.468,512.592,515.469,519.593,523.718,526.5949999999999,528.706,532.442,536.178,539.914,541.931,546.056,549.0,551.406,553.536,556.801,560.925,563.802,567.926,571.192,574.927" y="82.54600000000005" svg_rhmargin="576.944" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cacy of topical bevacizumab (Avastin) eye drops against corneal</text>
  <text x="348.436,352.56,355.825,359.95,363.686,367.483,370.359,373.625,377.749,379.766,383.502,386.379,388.396,391.661,395.397,397.803,399.821,403.945,408.069,410.086,414.931,420.685,423.562,427.297,430.563,432.969,436.234,439.111,443.9,449.264,452.141,455.406,459.531,464.365,469.73,471.747,473.765,477.89,482.676,487.189,491.314,495.439,500.25,506.392,510.517,514.641,517.047,521.172,524.907,526.925,533.067,537.191,539.2080000000001,544.014,548.138,552.263,556.387,560.511,562.529,566.653,570.778,574.902" y="91.55999999999995" svg_rhmargin="576.919" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neovascularization. Graefes Arch Clin Exp Ophthalmol 2009;247:</text>
  <text x="348.436,352.561,356.686,360.811" y="100.51700000000005" svg_rhmargin="364.935" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">1375</text>
  <text x="364.99" y="100.51700000000005" svg_rhmargin="368.726" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="368.732,372.857,376.982" y="100.51700000000005" svg_rhmargin="378.999" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">82.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,356.677,360.801,363.678,366.943,371.225,375.349,379.862,381.879,386.134,391.035,393.912,397.177,401.302,405.038,409.263,412.999,418.363,420.38,424.625,430.38,433.256,437.381,443.134,445.54,449.665,453.934,456.34,460.076,463.341,465.747,469.872,472.748,475.625,479.898,486.04,490.164,494.354,498.478,500.496,504.231,506.637,509.902,514.138,517.404,519.421,523.545,527.67,531.406,533.423,537.664,541.401,544.277,548.402,554.155,556.561,560.686,564.989,568.725,572.85" y="109.47400000000005" svg_rhmargin="576.974" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[35] Kruse FE, Tseng SC. Growth factors modulate clonal growth and</text>
  <text x="348.436,352.561,354.578,356.984,359.39,362.655,365.532,368.797,372.921,375.327,377.345,381.081,383.487,385.623,389.748,393.873,396.508,400.632,403.038,405.634,408.9,413.024,415.041,417.447,421.572,424.448,427.799,431.924,434.546,437.422,441.158,445.283,449.407,451.424,453.83,456.484,458.502,460.519,466.661,470.785,474.521,476.538,479.217,482.953,487.077,491.202,493.843,497.108,501.232,504.109,508.233,511.498,515.234,517.2510000000001,519.919,523.184,527.309,529.326,531.732,535.857,539.122,541.139,543.157,547.281,553.423,555.44,558.127,560.533,564.658,568.393,571.659,574.535" y="118.43100000000004" svg_rhmargin="576.941" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">differentiation of cultured rabbit limbal and corneal epithelium. Invest</text>
  <text x="348.436,354.578,358.703,362.827,365.233,369.357,373.093,375.193,381.335,385.459,387.476,389.988,395.353,397.371,400.248,402.744,406.479,409.745,411.762,414.252,418.376,422.5,426.625,430.749,432.767,436.891,441.016,443.105,447.23,451.354,455.479" y="127.38900000000001" svg_rhmargin="459.603" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Ophthalmol Vis Sci 1993;34:1963</text>
  <text x="459.611" y="127.38900000000001" svg_rhmargin="463.347" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="463.353,467.478,471.603" y="127.38900000000001" svg_rhmargin="473.62" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">76.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,353.801,357.926,360.681,366.046,372.076,374.093,376.838,382.203,386.327,389.933,394.058,397.794,400.477,407.949,409.966,412.722,420.194,423.777,426.183,428.2,431.077,433.754,439.119,441.525,443.542,446.226,449.492,451.898,454.616,458.352,460.37,462.387,465.047,470.412,474.148,476.895,480.16,484.152,486.169,489.905,492.782,495.433,498.698,502.822,506.77,510.895,513.301,517.315,520.58,522.473,524.491,528.085,530.1020000000001,532.904,536.64,539.516,543.448,549.201,551.607,555.732,558.414,560.82,564.556,567.654,570.06,574.185" y="136.346" svg_rhmargin="577.062" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[36] Yu CQ, Zhang M, Matis KI, et al. Vascular endothelial growth factor</text>
  <text x="348.437,354.579,357.734,361.859,363.876,367.485,369.891,373.041,375.918,377.123,380.388,384.512,387.27,391.395,394.527,398.263,400.28,401.443,405.568,408.833,411.591,415.327,418.592,419.755,422.631,425.763,429.888,433.624,435.514,438.391,440.408,441.58,443.986,447.986,451.722,454.987,457.68,460.086,461.365,467.508,471.513,475.638,477.919,482.045,485.78,487.671,493.813,497.818,499.835,501.05,506.415,508.433,511.31,512.445,516.181,519.446,521.4630000000001,522.593,526.717,530.7,534.824,538.948,540.847,544.971,548.954,550.971,555.096,559.102,563.226" y="145.36" svg_rhmargin="567.35" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">mediates corneal nerve repair. Invest Ophthalmol Vis Sci 2008;49:3870</text>
  <text x="567.214" y="145.36" svg_rhmargin="570.95" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="570.899,575.023" y="145.36" svg_rhmargin="577.04" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,354.19,357.926,362.051,365.16,369.673,371.69,374.798,378.923,382.659,386.395,389.66,392.536,396.661,400.785,402.803,408.945,412.1,416.224,418.241,421.34,425.465,429.201,431.219,437.36,441.485,443.502,447.238,451.363,454.504,457.38,459.397,462.497,467.862,471.598,474.474,477.739,481.864,483.881,487.617,490.494,493.619,496.884,501.008,505.133,509.257,511.663,515.787,519.052,521.07,523.087,526.823,528.84,531.997,535.733,538.609,542.734,548.487,550.893,555.018,558.13,560.536,564.272,567.537,569.943,574.068" y="154.317" svg_rhmargin="576.945" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[37] Gan L, Fagerholm P, Palmblad J. Vascular endothelial growth factor</text>
  <text x="348.437,350.843,356.208,360.721,366.474,370.598,373.004,378.425,382.161,386.285,390.41,395.772,397.79,400.196,403.07300000000004,408.471,411.348,414.613,417.878,421.144,425.268,427.674,431.798,434.675,440.047,445.412,449.925,455.678,459.803,465.167,467.654,471.779,477.122,479.139,483.264,488.63,491.035,495.16,498.425,503.766,506.643,509.908,513.644,517.768,519.785,523.521,525.927,528.028,532.153,536.278,541.635,545.759,548.165,553.539,556.805,560.929,563.806,567.93,571.195,574.931" y="163.274" svg_rhmargin="576.948" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">(VEGF) and its receptor VEGFR-2 in the regulation of corneal</text>
  <text x="348.437,352.562,355.827,359.951,363.687,367.484,370.361,373.626,377.75,379.768,383.504,386.38,388.398,391.663,395.399,397.805,399.822,403.947,408.072,414.252,417.988,422.113,426.238,432.336,438.09,442.215,446.339,450.464,454.589,460.738,464.863,468.128,471.864,473.881,475.898,480.023,483.759,485.776,491.917,497.282,500.547,502.953,506.68899999999996,512.836,518.978,523.102,527.227,529.633,533.757,537.493,539.51,545.652,549.777,551.7940000000001,557.96,561.696,564.961,568.697,572.821" y="172.23199999999997" svg_rhmargin="576.945" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neovascularization and wound healing. Acta Ophthalmol Scand</text>
  <text x="348.437,352.562,356.687,360.813,364.938,366.956,371.081,375.206,377.223,379.791,383.915,388.041" y="181.18899999999996" svg_rhmargin="392.165" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2004;82: 557</text>
  <text x="392.147" y="181.18899999999996" svg_rhmargin="395.883" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="395.889,400.014,404.139" y="181.18899999999996" svg_rhmargin="406.156" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">63.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,351.313,354.578,358.703,362.827,366.563,369.525,372.401,378.625,380.642,383.584,388.949,393.074,397.198,401.323,404.276,409.641,413.377,415.394,418.335,423.7,425.718,431.86,434.833,439.346,443.082,445.099,447.985,451.25,453.656,456.602,460.338,462.355,464.372,467.316,472.681,476.805,482.947,487.072,490.337,494.461,497.418,501.154,503.56,507.684,510.561,514.297,517.202,520.938,523.815,527.939,533.693,536.099,540.224,543.222,545.628,549.364,552.629,555.035,559.16,562.0369999999999,564.991,568.727,572.851" y="190.14599999999996" svg_rhmargin="576.975" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[38] Jeong JH, Chun YS, Kim ES, et al. Compensatory growth factor and</text>
  <text x="348.437,351.702,355.438,357.844,361.969,366.093,368.11,372.235,375.5,377.915,380.791,384.057,386.933,391.058,395.182,399.307,402.183,405.448,407.846,409.863,413.988,416.406,418.812,422.078,425.813,428.69,431.567,433.923,437.659,440.065,442.471,445.736,448.613,451.043,453.92,458.045,462.169,465.434,469.559,473.683,475.7,479.825,483.949,487.214,489.62,491.638,495.374,499.109,501.126,503.537,507.661,510.926,514.662,518.398,521.733,523.751,527.016,531.14,537.282,541.018,545.143,547.527,549.544,553.669,555.686,558.951,562.216,564.622,566.64,570.764,574.889" y="199.10299999999995" svg_rhmargin="576.906" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cytokine response in tears after subconjunctival bevacizumab injection.</text>
  <text x="348.437,353.802,357.926,360.803,364.927,368.193,371.929,374.457,378.581,382.706,386.83,390.955,392.972,397.096,401.221,403.311,407.435,411.559,415.684" y="208.11699999999996" svg_rhmargin="419.808" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cornea 2011;30:1071</text>
  <text x="419.813" y="208.11699999999996" svg_rhmargin="423.549" style="fill:#171615;font-family:DPNDHC+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="423.555,427.679" y="208.11699999999996" svg_rhmargin="429.696" style="fill:#171615;font-family:DPNDHB+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text svg_rhmargin="193.001" x="71.887,77.442,81.674,85.739,89.971,94.37,97.001,101.066,103.385,106.015,110.08,111.491,113.643,116.276,122.827,126.892,131.451,132.862,136.927,138.337,142.57,146.635,149.214,151.118,155.518,159.917,164.317,168.717,170.622,173.25,177.65,182.049,184.201,188.601,193.0" y="9.870999999999981" style="fill:#171615;font-family:DPNDFL+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Huang et al. Medicine (2018) 97:34 </text>
  <text x="542.723,549.944,554.503,559.317,561.31,565.869,567.861,572.508" y="9.870999999999981" svg_rhmargin="577.067" style="fill:#171615;font-family:DPNDFK+AdvOT34fe1490.B;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Medicine</text>
  <text x="320.032,324.432" y="739.625" svg_rhmargin="328.832" style="fill:#171615;font-family:DPNDMJ+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">10</text>
 </g>
</svg>
